16 of the world’s 20 largest medical device companies have invested in at least 1 healthcare startup since 2016.
New healthcare technologies — targeting everything from chronic pain to cataracts — are entering the $530B medical device market.
And incumbent medical device manufacturers are pouring money into these emerging and potentially disruptive technologies.
For example, in February 2020, ResMed invested $27M in Nyxoah, a startup commercializing a novel neurostimulation-based therapy for Obstructive Sleep Apnea (OSA).
That same month, Philips (through its Philips Health Technology Ventures arm) participated in a $15M Series C round for Carevive Systems, a digital platform for oncology care management.
Below, we take a look at the investment activity of the world’s 20 largest medical device companies.
